Suturion Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$2.01M
- Investors
-
13
Suturion General Information
Description
Developer of a surgical device designed to solve the big issues in abdominal wall closure. The company offers a surgical sewing machine that reduces abdominal closure time, enabling surgeons to lower the risk of incisional hernia and the risk of prick injuries.
Contact Information
Website
www.suturion.comCorporate Office
- The Spark
- Scheeletorget 1
- 223 63 Lund
- Sweden
Corporate Office
- The Spark
- Scheeletorget 1
- 223 63 Lund
- Sweden
Suturion Timeline
Suturion Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Later Stage VC | 21-Oct-2026 | $2.01M | Completed | Generating Revenue | ||
| 11. Grant | 23-Apr-2026 | Completed | Generating Revenue | |||
| 10. Accelerator/Incubator | 01-Jan-2026 | Completed | Generating Revenue | |||
| 9. Later Stage VC | 15-Feb-2024 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | 23-May-2023 | Completed | Generating Revenue | |||
| 7. Early Stage VC | 30-Jul-2022 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 10-Jun-2022 | Completed | Generating Revenue | |||
| 5. Early Stage VC | 07-Jun-2021 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 23-Jun-2020 | $213K | $213K | Completed | Generating Revenue | |
| 3. Grant | 01-Mar-2020 | $124K | Completed | Generating Revenue |
Suturion Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preference | ||||||||
| Preference | ||||||||
| Preference | 28,000 | $47.76 | $47.76 | 1x | $47.76 | 19.71% | ||
| Preference | 10,000 | $19.1 | $19.1 | 1x | $19.1 | 7.04% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Suturion Patents
Suturion Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12622691-B2 | Crimping device and method | Active | 19-Jan-2024 | ||
| US-20250235207-A1 | Crimping device and method | Active | 19-Jan-2024 | ||
| EP-4324406-A1 | Crimping device | Pending | 17-Aug-2022 | ||
| US-D1019947-S1 | Control for suturing device | Active | 09-Aug-2022 | ||
| US-D1061885-S1 | Suturing device | Active | 08-Apr-2022 |
Suturion Signals
Suturion Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cradle Growth | Growth/Expansion | |||
| Medtech4Health | Not-For-Profit Venture Capital | |||
| MedTech Innovator | Accelerator/Incubator | |||
| Impilo | PE/Buyout | Minority | ||
| ScaleUp Life Science Invest | Angel Group | Minority |
Suturion FAQs
-
When was Suturion founded?
Suturion was founded in 2018.
-
Where is Suturion headquartered?
Suturion is headquartered in Lund, Sweden.
-
What is the size of Suturion?
Suturion has 10 total employees.
-
What industry is Suturion in?
Suturion’s primary industry is Surgical Devices.
-
Is Suturion a private or public company?
Suturion is a Private company.
-
What is Suturion’s current revenue?
The current revenue for Suturion is .
-
How much funding has Suturion raised over time?
Suturion has raised $7.61M.
-
Who are Suturion’s investors?
Cradle Growth, Medtech4Health, MedTech Innovator, Impilo, and ScaleUp Life Science Invest are 5 of 13 investors who have invested in Suturion.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process